C. Dreezen

Details der Publikationsliste

Zeitraum

1999 - 2004

Anzahl

32

Co-Autoren

The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment (2004)

Florence, E., Dreezen, C., Schrooten, W., Van Esbroeck, M., Kestens, L., Fransen, K., ...

Our objective was to study the evolution of CD4 cell count five years after starting highly active antiretroviral treatment (HAART) in a clinical setting. The study was performed at the HIV...

Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe (2004)

Florence, E., Schrooten, W., Dreezen, C., Gordillo, V., Nilsson Schönnesson, L., Asboe, D., ...

This is an electronic version of an article published in AIDS Care. 2004 Jul;16(5):550-7. AIDS Care is available online at informaworldTM

Five-year immunological outcome of highly active antiretroviral treatment in a clinical setting: results from a single HIV treatment centre (2004)

Schrooten, W., Florence, E., Dreezen, C., Van Esbroeck, M., Fransen, K., Alonso, A., ...

Our objective was to study the evolution of CD4 cell count five years after starting highly active antiretroviral treatment (HAART) in a clinical setting. The study was performed at the HIV...

The use of complementary and alternative medicine by persons with HIV infection in Europe (2003)

Colebunders, R., Dreezen, C., Florence, E., Pelgrom, Y., Schrooten, W.

Between June 1996-September 1997 and December 1998-December 1999, two surveys using an anonymous questionnaire were carried out in Europe among persons living with HIV infection. The questionnaire...

Self-reported signs of lipodystrophy by persons living with HIV infection (2002)

Dreezen, C., Schrooten, W., De Mey, I., Goebel, F. D., Dedes, N., Florence, E., ...

OBJECTIVE: To identify risk factors for the development of lipodystrophy in HIV infected patients on highly active antiretroviral therapy. METHODS: A survey among patients with HIV infection using an...

Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study) (2002)

Florence, E., Dreezen, C., Desmet, P., Smets, E., Fransen, K., Vandercam, B., ...

This is the author’s version of a work accepted for publication by International Medical Press. Changes resulting from the publishing process, including peer review, editing and formatting, might...

Rheumatological complications associated with the use of indinavir and other protease inhibitors (2002)

Florence, E., Schrooten, W., Verdonck, K., Dreezen, C., Colebunders, R.

Several cases are reported of rheumatological pathology (temporomandibular dysfunction, frozen shoulder, Dupuytren's disease, and tendinitis) most probably related to the intake of indinavir in HIV...

Financial situation of people living with HIV in Europe (2002)

Schrooten, W., Dreezen, C., Borleffs, J., Dijkgraaf, M., Borchert, M., De Graeve, D., ...

The objective was to investigate the financial situation of people living with HIV in Europe. Two surveys using an anonymous questionnaire were organized in Europe among people living with HIV, the...

Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study) (2001)

Dreezen, C, Desmet, P, Smets, E, Fransen, K, Vandercam, B, ...

Objectives: To compare the efficacy, tolerability and safety of a ritonavir 400 mg/saquinavir hard gel fomulation 400 mg twice daily versus an indinavir 800 mg once every 8 In containing first-line...

Participants in HIV clinical trials in Europe (2001)

Borchert, M, Dreezen, C, Baratta, C, Smets, E, Kosmidis, J, ...

In recent years an increasing number of antiretrovirals have become available. In order to define the optimal treatment regimens an increasing number of clinical trials are needed.

Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment (2001)

Schrooten, W., Colebunders, Robert, Youle, M., Dedes, N., Koitz, G., ...

BACKGROUND: A high proportion of individuals receiving highly active antiretroviral treatment (HAART) complain of sexual dysfunction (SD), encompassing a lack of desire or erectile dysfunction....

Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment (2001)

Schrooten, W., Colebunders, Robert, Youle, M., Dedes, N., Koitz, G., ...

BACKGROUND: A high proportion of individuals receiving highly active antiretroviral treatment (HAART) complain of sexual dysfunction (SD), encompassing a lack of desire or erectile dysfunction....

Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment (2001)

Schrooten, W., Colebunders, Robert, Youle, M., MOLENBERGHS, Geert, Dedes, N., Koitz, G., ...

BACKGROUND: A high proportion of individuals receiving highly active antiretroviral treatment (HAART) complain of sexual dysfunction (SD), encompassing a lack of desire or erectile dysfunction....

Hospital services for people with HIV infection in Flanders: patients' satisfaction (2001)

Colebunders, R., Bottieau, E., Willaeys, V., Fleerackers, Y., De Droogh, E., ...

This is an electronic version of an article published in AIDS Care. 2001 Apr;13(2):191-6. AIDS Care is available online at informaworldTM

Antiretroviral treatments used among adults with HIV infection in Europe (2001)

Colebunders, R., Schrooten, W., Dreezen, C., Baratta, C., Florence, E., Finazzi, R., ...

This is an electronic version of an article published in AIDS Care. 2001 Feb;13(1):5-14. AIDS Care is available online at informaworldTM

Participants in HIV clinical trials in Europe (2001)

Schrooten, W., Borchert, M., Dreezen, C., Baratta, C., Smets, E., Kosmidis, J., ...

In recent years an increasing number of antiretrovirals have become available. In order to define the optimal treatment regimens an increasing number of clinical trials are needed. Our objective was...

Utilization of healthcare services by people living with HIV/AIDS in Europe (2000)

Baratta, C., Schrooten, W., Colebunders, R., Garcia, F., Caldeira, L., Coppieters, Y., ...

Our objective was to compare the utilization of healthcare/support services for people with HIV infection in Europe. Between August 1996 and September 1997 self-administered anonymous questionnaires...

Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine (2000)

Gisolf, E. H., Dreezen, C., Danner, S. A., Weel, J. L. F., Weverling, G. J.

Liver enzyme elevation (LEE) is commonly observed after combination antiretroviral therapy (ARVT) for HIV infection is begun. Potential risk factors for LEE after treatment with ritonavir and...

Primary care involvement in human immune deficiency virus infection - a pan-European view (2000)

Tomlinson, D. R., Colebunders, R., Coppieters, Y., Dreezen, C., Andraghetti, R., Fleerackers, Y., ...

This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Family Practice following peer review. The definitive publisher-authenticated version Fam Pract. 2000...